Bellcore May Find New Life After Sale - If Researcher Exodus Is Stemmed

After the April announcement that the seven regional telephone companies would be selling Bellcore, their jointly funded research arm, the question many telecommunications experts are asking is whether the move was made in time to preserve its intellectual capital and, thereby, its future. Growing competition over the past several years among the so- called Baby Bells has diminished their willingness to use the shared research resource, contributing to the decision to sell the Livingston, N.J.

Written byFranklin Hoke
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

After the April announcement that the seven regional telephone companies would be selling Bellcore, their jointly funded research arm, the question many telecommunications experts are asking is whether the move was made in time to preserve its intellectual capital and, thereby, its future.

Growing competition over the past several years among the so- called Baby Bells has diminished their willingness to use the shared research resource, contributing to the decision to sell the Livingston, N.J.-based organization, formally known as Bell Communications Research Co. It has also made it increasingly difficult for Bellcore scientists to pursue their mission of creating tomorrow's communications systems. As a result--although Bellcore continues to hire young computer scientists and engineers aggressively, even during the current uncertain period- -many of the more talented senior researchers have been quietly leaving Bellcore for several years, and others may follow them.

"I have felt that, over the last couple of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies